Read more
10:54 ยท 6 May 2026

USDJPY: another intervention by Japanese authorities, yen gains 1.00% ๐Ÿ“Œ

USDJPY was hit again today by a strong wave of yen buying, with the pair falling from the upper 157.700 area to 155.030. The move is being interpreted as another intervention by Japanese authorities. The timing fits the recent pattern: low liquidity around Japanese holidays and the transition from the Asian to the European session, when official flows can have a greater market impact. At the peak of the move, the yen strengthened by nearly 2%, toward the 155 area — the strongest level since February 24, 2026 — after Finance Minister Satsuki Katayama warned against speculative movements in the FX market.

This is another such intervention following last week’s large-scale operation. At that time, Bank of Japan money market data suggested that Tokyo may have spent around 5.48 trillion yen, or roughly 35 billion USD, to support the yen after USDJPY broke above the 160 level. The key signal for investors is that Japan’s Ministry of Finance is no longer limited to verbal warnings, but is actively attempting to cap USDJPY gains, particularly in the 158–160 zone. At the same time, rapid rebounds following earlier interventions show that these actions are buying time rather than changing the broader trend itself. Levels above 160 were also a critical point during the July 2024 intervention.

The fundamental backdrop remains difficult for the yen: the wide interest rate differential between the US and Japan, Japan’s dependence on energy imports, and geopolitical pressure related to the Strait of Hormuz continue to support the dollar and weaken the yen. The recent improvement in sentiment surrounding a potential US–Iran agreement has helped Tokyo through lower oil prices and a weaker USD, but if this pressure does not continue to ease — or if the Bank of Japan does not adopt a more hawkish stance — investors may continue to support the current weakening trend in JPY.

6 May 2026, 13:08

BREAKING: The US100 extends its gains following the Axios report ๐Ÿš€

5 May 2026, 22:20

Daily Summary: Wall Street Hits New Records as Oil Prices Cool

5 May 2026, 18:44

Unexpected beneficiaries of the AI boom: Caterpillar

5 May 2026, 18:02

BREAKING: US ISM data gives more space to dovish FED stance ๐Ÿ’ก

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.